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BACKGROUND: Recent studies suggest that older patients in the United Kingdom are not benefiting as much from improvements in
cancer treatments as their younger counterparts. We investigate whether this might be partly due to differential referral rates using
ovarian cancer as an example.
METHODS:From the General Practice Research Database (GPRD), we identified all women aged 40–80 years on 1 June 2002 with a
Read code for ovarian cancer between 1 June 2002 and 31 May 2007. Using these records, we compared the GPRD incidence of
ovarian cancer with rates compiled from the UK cancer registries and investigated the relationship between age and coded
investigations for suspected ovarian cancer.
RESULTS:The GPRD rates peaked earlier, at 70–74, and were lower than registry rates for nearly all ages particularly for patients over
59. The proportion investigated or referred by the GP decreased significantly with age and delays between first coded symptom and
investigation showed a U-shaped distribution by age.
CONCLUSIONS: GPs appear to be less likely to recognise and to refer patients presenting with ovarian cancer as they get older. If our
findings extend to other cancers, lack of or delays in referral to secondary care may partly explain poor UK cancer mortality rates of
older people.
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Cancer is a disease that predominantly affects older people and in
our ageing population increasing numbers of people are going to
be affected by this disease. However, significant advances in cancer
treatment seem not to be benefiting older people as much as they
could. A recent study by the EUROCARE group found that the gap
in survival between older and younger European cancer patients is
getting wider (Quaglia et al, 2009). The United Kingdom, which
already has lower cancer survival rates than most of Europe
(Berrino et al, 2007), seems to be doing particularly badly where
older people are concerned. A comparison of data from the World
Health Organization registry database suggests little or no
improvement in cancer mortality rates for the UK elderly during
the last decade, and that cancer mortality rates for patients over
64 compare badly with other Northern and Western European
countries and the United States (Moran and Moeller, 2009). The
cause of this discrepancy is unclear, but as most patients
experiencing cancer-related symptoms in the United Kingdom
present first to primary care (Kirwan et al, 2002; Allgar and Neal,
2005), it is possible that older cancer patients are being managed
differently from their younger counterparts by their GP.
The existence of large primary care databases of electronic
patient records provides the opportunity to investigate GPs
management of cancer patients in the United Kingdom using a
large cohort of patients. We have already been using the General
Practice Research Database (GPRD) to investigate primary care
delay using ovarian cancer as an example (Tate et al, 2009), and
have shown that the time between the first recorded relevant
symptom and first recorded referral is typically around 10 weeks.
The purpose of this study is to investigate whether patient age is
a factor in this delay and in particular to investigate the effect of
patient age on:
1. The incidence of coded diagnoses for ovarian cancer in general
practice (compared with the UK cancer registry rates).
2. Investigation or referral before diagnosis of ovarian cancer.
3. The delay between a patient first reporting an ovarian cancer-
related symptom and first recorded referral or investigation.
MATERIALS AND METHODS
Data and measures used
Subjects The GPRD (GPRD, 2009) is one of the largest primary
care databases in the United Kingdom. It contains anonymised
longitudinal data on a representative sample of the UK population.
Records are being collected on over 3.6 million currently registered
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spatients (approximately 13 million total) who are registered for care in
general practice from around 488 primary care practices throughout
the United Kingdom. These records are created during consultations
or when processing correspondence, and are widely used in research
on disease epidemiology, drug safety and adverse drug reactions
(Hansell et al, 2004; Majeed et al, 2008; Jones et al, 2009).
This study forms part of an ongoing investigation of prognostic
symptoms and primary care delays in ovarian cancer (Tate et al,
2009). The data set was provided under the MRC licence scheme
and access was approved by the Independent Scientific Advisory
Committee (Protocol 07_069). The target population consisted of
all females between 40 and 80 years of age (inclusive) who were
alive and registered with a GPRD contributing practice on 1 June
2002. From this population, all women with an incident diagnosis
of ovarian cancer recorded during 1 June 2002–31 May 2007 were
identified (N¼1166). Women with a previous diagnosis of ovarian
cancer were excluded. An incident diagnosis of ovarian cancer was
defined by a first Read code recorded in the patient’s clinical or
referral record, that is, B440.00 (Malignant neoplasm of ovary),
B440.11 (Cancer of ovary) or B44.00 (Malignant neoplasm of ovary
and other uterine adnexa).
The UK cancer registry incidence rates for 2002–06 were
provided by the Statistical Information Team at Cancer Research
UK (CRUK, 2009). These rates represent the most recent statistics
that are currently available. To compare these rates with those
recorded in the GPRD, we used only those (1057) patients who
were coded as being diagnosed with ovarian cancer between 1 June
2002 and 31 December 2006. Denominator data for the female
GPRD patient population were used to calculate rates of recorded
ovarian cancer. These included information on the number of
patients registered in the GPRD and equivalent person-years
stratified by calendar year, age and practice.
For the description of investigations/referrals, we selected all
ovarian cancer cases (from the 1166 cases recorded during 1 June
2002–31 May 2007) that had been registered for at least 1 year
before the GP had recorded a diagnosis (n¼1107). For the
investigation of delays, we used only those patients who had been
recorded as having a relevant investigation and who had been
registered for at least 1 year before the date of first recorded
investigation.
MEASURES
Read codes for a relevant investigation or referral for ovarian
cancer were identified and grouped into the following categories:
(1) oophorectomy, (2) laparoscopy, (3) laparotomy, (4) referral to
gynaecologist, (5) CA125 test, (6) CAT scan and (7) ultrasound. Of
these, 1–3 were subcategorised as invasive investigations and 4–7
as non-invasive investigations. Although 1–3 are often used to
treat ovarian cancer, they also often serve as an investigation and
thus may be the first recorded procedure. Read codes for the most
commonly recorded ovarian cancer-related symptoms were
identified and grouped into the following 11 categories: (1)
abdominal pain, (2) pelvic pain, (3) back pain, (4) abdominal
distension/bloating, (5) indigestion, (6) nausea and vomiting,
(7) constipation/change in bowel habit, (8) urogenital symptoms,
(9) appetite weight, (10) tiredness and (11) breathing problems.
Further details of how these measures were obtained, together with
the code list for symptoms, are published elsewhere (Tate et al, 2009).
Data analysis
Rates of incident-coded diagnosis were calculated by dividing the
number of first-time diagnosis codes for ovarian cancer by the
number of person-years of women registered in the GPRD during
the corresponding time period and stratified by 5-year age bands.
The percentage of each age group having a relevant referral or
investigation for ovarian cancer was calculated for each type of
investigation by dividing the number of cases with at least one
code for that investigation in the year before and including the
diagnosis date, by the total number of cases in that age group.
The delay between a symptom being first recorded and
investigation was calculated by estimating the time from the GP
first recording the symptom to the first relevant investigation.
The binomial test was used to test for differences between the
proportions reported in the GPRD and the cancer registries and a
non-parametric trend test (Stata’s nptrend) was used to test for
trends by age (in years). Data management was undertaken using
MySql (http:/www.mysql.com) and statistical analyses were performed
using Stata 10 (Stata Corporation, College Station, TX, USA).
RESULTS
Comparison with cancer registry data
The rate of recorded diagnosis of ovarian cancer in the GPRD was
significantly lower than the UK incidence rate for nearly all age
groups, with the difference being greatest in those aged 460 years
(Table 1). The GPRD rates peaked at 70–74, in contrast to the
registry-based incidence rate in which the highest rate was in the
80–84 age group.
Investigations
Of the 1107 cases that were registered with a GPRD practice for at
least 1 year before the date of first coded diagnosis, 810 (73%) were
Table 1 The rates of diagnosis codes in the GPRD between June 2002 and December 2006 compared with the UK registry-based rate for 2002–06
(CRUK, 2009)
GPRD 2002–07
UK registries 2002–06 Difference
Age at diagnosis (years) Cases Rate/100k Rate/100k Rate/100k P-value
40–44 32
a 10.4 11.3 0.9 0.65
45–49 73 14.6 19.3 4.7 0.02
50–54 103 22.1 28.5 6.4 0.01
55–59 171 34.5 40.9 6.4 0.03
60–64 151 37.8 53.1 15.3 o0.001
65–69 169 49.1 60.8 11.7 0.01
70–74 154 49.5 66.3 16.8 o0.001
75–79 135 49.0 70.6 21.6 o0.001
80–84 69
a 46.1 73.3 27.2 o0.001
All (40–84) 1057 32.5 41.4 8.9 o0.001
Abbreviation: GPRD, General Practice Research Database.
aOwing to the sampling strategy of selecting patients aged between 40 and 80 on 1 June 2002, there are fewer cases
than would normally be expected in the youngest and oldest age bands.
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scoded as having at least one relevant investigation or referral to a
gynaecologist in the year before diagnosis. This proportion
decreased with age for most types of investigation (Table 2), with
82% aged o55 years having had at least one recorded investigation
compared with 75% aged between 55 and 69 years and 66% of
those aged X70 years. The decreases with age were significant for
both invasive and non-invasive investigations (Pp0.001).
Delay between reporting a symptom and investigation
The four most commonly recorded ovarian cancer-related
symptom groups in the year before coded diagnosis or first
investigation (if recorded) were abdominal pain (43%), urinary/
genital problems (23%), abdominal distension (22%) and con-
stipation (21%), with the next most common being nausea/
vomiting (12%). Of the 810 patients recorded as having at least one
investigation, 804 had been registered a full year before the first
recorded investigation date. Of the latter, 640 (77%) were coded
with at least one relevant symptom during the year before
investigation and 545 (68%) with one of the four most common
symptoms. Of those (297 cases) with no recorded investigation,
72% had at least one relevant symptom and 64% had one of the
four most common symptoms in the year before coded diagnosis.
There was a slight increase in symptoms with increased age, but
the trend was not significant at the 0.05 level (P¼0.08 for any
symptom and P¼0.38 for any of the most common four).
The median (IQR) time in weeks between the first recorded
relevant symptom and first investigation or referral to the
gynaecologist was 10.5 (2, 32) for the 11 relevant symptoms and
7 (1, 23) for the four most common symptoms. Figure 1 shows the
distribution of time between first reporting any one of the relevant
symptoms and referral for each age category. The median delays
have a U-shaped distribution, with the younger and older patients
having longer delay than those in the middle age groups. Although
the distribution of delay in the younger age group was similar to
that of older cases, the overall trend was for delays to increase with
age (P¼0.003). The biggest differences were between those aged
X70 years compared with those aged between 45 and 69 years. A
similar pattern was observed for the four most common symptoms
(data not shown).
DISCUSSION
This study not only shows that age has a major effect on how
GPs manage women with ovarian cancer, but also shows that
they are less likely both to code a diagnosis and to refer patients
for gynaecological investigation when they are older. Our results
also suggest that when GPs do refer elderly patients for
investigation, they are slower to do so than for their middle-aged
counterparts.
This study uses recently recorded information from a large
cohort of patients representative of the UK population. Large
primary care databases such as the GPRD enable the study of
patterns of management of patients in primary care in a large
unselected cohort of patients and are ideal for studying relatively
rare diseases such as ovarian cancer. However, a disadvantage of
using records where data are collected for clinical rather than
research purposes is that coding may be incomplete. This was
shown in our previous study (Tate et al, 2009), in which we found
inaccuracies in the dating of diagnosis, and again in this study in
which we find that rates of coded diagnosis of ovarian cancer are
9% lower than the UK incidence rates.
This study was based on coded data and did not use information
from the free text fields, which, owing to the costs of anonymisa-
tion, was not available for this study. Thus, we may have missed
diagnoses, referrals and symptoms that GPs chose to record only
in the free text. Although there is no reason to suppose that patient
age affects how GPs use the free text fields, this is an important
Table 2 Proportion of cases having relevant surgery or investigation for ovarian cancer in the year before diagnosis by age
Age at diagnosis (years) 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 Total
Number of cases 31 69 105 177 164 174 171 139 77 1107
Proportion having invasive investigation
Oophorectomy* 0.52 0.33 0.3 0.29 0.25 0.2 0.18 0.12 0.16 0.23
Laparotomy 0.06 0.13 0.1 0.12 0.1 0.09 0.13 0.14 0.1 0.11
Laparoscopy 0.03 0.04 0.03 0.03 0.02 0.02 0.02 0.03 0.04 0.03
Any of above* 0.55 0.42 0.36 0.38 0.3 0.26 0.28 0.22 0.26 0.31
Proportion referred to gynaecologist or having non-invasive investigation
Gynaecology* 0.48 0.57 0.45 0.47 0.43 0.38 0.32 0.36 0.35 0.41
CA125 0.19 0.29 0.32 0.19 0.24 0.27 0.24 0.22 0.17 0.24
CAT scan 0.06 0.13 0.2 0.15 0.14 0.18 0.15 0.17 0.17 0.16
Ultrasound* 0.45 0.39 0.39 0.35 0.29 0.28 0.29 0.24 0.27 0.31
Any of the above 4* 0.68 0.78 0.75 0.67 0.66 0.68 0.61 0.6 0.57 0.66
Any of the above* 0.9 0.81 0.8 0.75 0.76 0.75 0.68 0.65 0.62 0.73
Abbreviation: CAT, computed tomography. *With P-value of o0.05 for negative trend with age (all items with an asterisk represent a P-value of p0.01).
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Figure 1 The distribution of time in weeks before a patient first
reporting any ovarian cancer symptom and being referred for a relevant
investigation, by age.
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sarea that warrants further investigation. However, the context of
consultations (e.g., home visit, telephone consultation) may have
an age-related influence on recording practices and this could be a
source of confounding in our analysis, as could investigations for
other conditions. Read codes often do not provide information on
the type of investigation or the site of the body where it is carried
out. So, for example, a code for imaging may relate to an
investigation for suspected ovarian cancer, or for some other
complaint. As a result, and also because older people are more
likely to have other complaints, we considered only investigations
that we were almost sure would pertain to an investigation for
suspected ovarian cancer.
The sampling strategy of setting the patient’s age at the start of
the study meant that there were fewer cases in the lower and upper
age groups than would be expected if we had sampled over the full
age range for the whole study period; thus, for example, there were
no 40 year olds after May 2003 and no 84 year olds until June 2006,
and thus the 40–44 and 80–84 age bands are overrepresented by
older and younger patients, respectively. We included these age
bands in our results for completeness. The start date of June 2002
meant that in the comparison with the cancer registry data, which
covered the full year, the first part of 2002 had no GPRD data.
However, we believe that this will have little impact on the results
as incidence rates are not changing rapidly.
As we only looked at one type of cancer, we do not know if our
results will generalise to other cancers. However, ovarian cancer
would seem to be a good example to study as it is one of the most
common cancers experienced by older women, and its prognosis is
greatly improved if it is diagnosed at an early stage (Falandry et al,
2008). It was one of the cancers found to have worse prognosis in
the United Kingdom than in other European countries (Berrino
et al, 2007).
To our knowledge, this is the first study to investigate age-
related differences between the incidence of codes in general
practice records for ovarian cancer and the cancer registries.
However, other studies have reported similar overall discrepancies
between GP recording and registry data, for all cancers (Pascoe
et al, 2008), and for ovarian cancer patients (Hamilton, 2009). It is
interesting that both these studies included information from the
free text. Haynes et al (2009) found that rates for solid cancers
coded in the Health Improvement Network database were lower
than those in the cancer registry and hypothesised that this could
be because their study included only cases with an unambiguous
Read code for ovarian cancer, whereas GPs may prefer to use a
more ambiguous code. This might also be true for our study and
could explain the lower overall rate.
The increasing disparity in incidence with age may be more
difficult to explain. One possible reason may be that GPs are less
motivated to record cancer diagnoses in older people if they have
other serious illnesses. Alternatively, recording details of the
disease could be deemed to be less important for older people – it
has been found that the stage or grade of tumour in cancer registry
data is more likely to be missing if the patient is elderly (De Rijke
et al, 1998; Adams et al, 2004). Another possible reason, which
might partly explain the earlier peak in recorded ovarian cancer in
the GPRD, could be a possible time lag between recording a
diagnosis in GP records and informing the cancer registries (data
for which come mostly from other sources including hospitals and
the death registry). There may also be non-clinical reasons for
differential patterns of recording; for example, older patients may
be more likely to consult at home or be diagnosed or referred to a
hospital visit for some other purpose.
Our results on investigations and referral agree with other
reports that have found that patients are less likely to be
investigated or treated for cancer if they are elderly (e.g., Turner
et al, 1999; Peake et al, 2003; Bouchardy et al, 2007). However,
most other studies are hospital based and do not investigate what
happens in primary care.
Few studies have investigated the relationship between delays
in cancer referrals and patient age and those that have show
conflicting results (Neal and Allgar, 2005). To our knowledge, the
only other study to look at ovarian cancer was that of Neal and
Allgar (2005), which was based on a large NHS survey of data
collected from patients with one of six types of cancer discharged
from hospital between July 1999 and June 2000. They found, in
contrast to our results, that referral delay (for ovarian and a
number of other cancers) decreased with patient age. However,
they used a different methodology from our study; the data were
based on patient reports that are prone to recall and selection bias,
which may be greater in older people. For example, older
people tend to be more forgetful and those who had experienced
long delays may have died before they could be included in the
survey. Other differences from our study were that the time
period between first reporting a symptom and delay was
unspecified and that mean rather than median delays were
compared. Another UK-based study, which examined factors
influencing delay in colorectal cancer (Robertson et al, 2004),
found a similar age-related distribution to ours, with the fastest
referrals being in the 50–64 age group. This same study also
examined breast cancer delays and found that these decreased
with increasing age. The authors suggest that differences in
delay for the different cancers depend on how the tumour
presents and also how common (and thus predictive) the
symptoms are in the group that are presenting. As with ovarian
cancer, colorectal cancer has nonspecific symptoms that may
include abdominal distension and abdominal pain. This may
explain why their findings are similar to ours at least for the
female cases, as these symptoms are commonly experienced by
women without cancer before and during the menopause and then
again in old age.
The lower rates of recording compared with cancer registries
suggest that primary care data may be less fit for the purpose of
measuring incidence in older age groups. It is important that the
quality of records is high in the elderly if we are to maximise health
gain from electronic patent records through disease surveillance
and monitoring and improvement of care. Despite this limitation,
this study, based on recent information from GP surgeries,
suggests that there is a decline in recorded investigation and
referral in older women for ovarian cancer. Such delays could be
an important cause of avoidable morbidity and mortality, and if
our results are generalisable to other cancers, they could
contribute to the lower survival rates and higher mortality rates
experienced in the United Kingdom compared with other
European countries.
The discrepancies we have shown in the apparent incidence of
ovarian cancer in the GPRD, as compared with the cancer registries,
have implications for further records-based research on care pathways
and on epidemiological research in this field. We are planning future
work on the different strategies for investigation used by GPs for
different age groups. Further work is also needed to explore whether
these findings generalise to other cancers and the extent of possible
confounding by differential recording practices in primary care for
the elderly.
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